Eustachian Tube Functions in Concurrent Chemoradiotherapy for Head and Neck Cancer Patients

Author(s):  
Akira Ohkoshi ◽  
Ryoukichi Ikeda ◽  
Jun Suzuki ◽  
Takaya Yamamoto ◽  
Ryo Ishii ◽  
...  
2021 ◽  
Author(s):  
Hundo Cho ◽  
Seok Yun Kang ◽  
Hyun Woo Lee ◽  
Yong Won Choi ◽  
Tae-Hwan Kim ◽  
...  

Abstract Background The risk of thromboembolic events (TEE) in cancer patients, especially those receiving cisplatin-based chemotherapy, is higher than that of general population. Methods The study investigated the incidence of TEE in 257 head and neck (H&N) cancer patients, during or within 6 months of completion of concurrent chemoradiotherapy (CCRT) with cisplatin, and analyzed factors affecting TEE occurrence. Results TEE occurred in 5 patients, an incidence rate of 1.9%. Khorana score was the only factor associated with TEE occurrence (p = 0.010). Conclusions The incidence of TEE in H&N cancer patients who underwent CCRT with cisplatin was relatively low when compared to other types of cancer. However, patients with a high Khorana score require more careful surveillance for possible TEE occurrence.


2009 ◽  
Vol 18 (7) ◽  
pp. 837-845 ◽  
Author(s):  
Agostino Paccagnella ◽  
Michela Morello ◽  
Maria C. Da Mosto ◽  
Carla Baruffi ◽  
Maria L. Marcon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document